PCOS: Perspectives from a Pediatric Endocrinologist and a Pediatric Gynecologist

    Alvina R. Kansra, Seema Menon
    Image of study
    TLDR The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.
    The document from 2013 provides insights into the diagnosis and treatment of Polycystic Ovary Syndrome (PCOS) in adolescents from the perspectives of a pediatric endocrinologist and a pediatric gynecologist. It notes that PCOS affects 4-12% of women of reproductive age and can lead to various health issues, including endometrial pathology, obesity, insulin resistance, and hyperandrogenemia. The prevalence among adolescents is around 3% based on an Iranian study. The disorder's pathogenesis is linked to genetic factors and disruptions in the hypothalamic-pituitary-gonadal axis. Clinically, PCOS presents with menstrual abnormalities and signs of hyperandrogenemia, such as hirsutism, acne, and alopecia. The document emphasizes the importance of accurate diagnosis, which relies on the presence of hyperandrogenism, chronic anovulation, and polycystic ovaries, and suggests that laboratory evaluation is crucial despite the absence of a definitive endocrine marker. Treatment focuses on managing symptoms and preventing comorbid conditions, with low-dose combination oral contraceptive pills (COCs) being effective for menstrual regulation and antiandrogen therapy for hirsutism. Lifestyle interventions are recommended for obesity management, and insulin-sensitizing agents may be used for insulin resistance. The document highlights the need for individualized care and the importance of early treatment to mitigate long-term health consequences.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  441 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results